Ann Surg Oncol

1. SHAFIQUE N, Farooq MS, Mattfeld V, Vargas GM, et al
   Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.
   Ann Surg Oncol. 2025 Sep 12. doi: 10.1245/s10434-025-18314.
   

   >> Share

   
   
2. BICHAKJIAN CK, Swetter SM, Carroll BT, Vidal NY, et al
   ICEMAN (Intelligent Choice of Excision Margin): A Randomized Controlled Trial of Adaptive Narrow Excision Versus Wide Excision for Adults with AJCC Stage I Cutaneous Melanoma.
   Ann Surg Oncol. 2025 Sep 8. doi: 10.1245/s10434-025-18282.
   

   >> Share

   
   

   
   Clin Cancer Res

3. SATO T, Butler MO, Piperno-Neumann S, Hassel JC, et al
   Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 patients.
   Clin Cancer Res. 2025 Sep 12. doi: 10.1158/1078-0432.CCR-25-1513.
   

   >> Share

   
   

   
   J Surg Oncol

4. TAQI K, Jonsson EL, Assadzad GE, Stockley C, et al
   Superparamagnetic Iron Oxide Tracer: A Magnetic Match to Gold Standard in Melanoma Sentinel Lymph Node Biopsy-A Systematic Review and Meta-Analysis.
   J Surg Oncol. 2025 Sep 10. doi: 10.1002/jso.70086.
   

   >> Share

   
   

   
   Melanoma Res

5. FUCINA S, Lerda L, Del Fabro A, Reato C, et al
   Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer.
   Melanoma Res. 2025 Sep 10. doi: 10.1097/CMR.0000000000001064.
   

   >> Share

   
   

   
   Oncogene

6. LEE YK, Heo HH, Park UH, Youn H, et al
   Tumor antigen PRAME promotes melanoma growth by inactivating p53 through the SIRT1-DBC1 axis.
   Oncogene. 2025 Sep 8. doi: 10.1038/s41388-025-03565.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share